{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:47:10Z","timestamp":1788817630210,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00115-024-01691-9","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:02:00Z","timestamp":1721052120000},"page":"811-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aktuelle Herausforderungen in der Behandlung der Opioidabh\u00e4ngigkeit","Challenges in the treatment of opioid dependence"],"prefix":"10.1007","volume":"95","author":[{"given":"Andreas","family":"Heinz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gutwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"Suppl 2","key":"1691_CR1","first-page":"S70","volume":"61","author":"D Vearrier","year":"2021","unstructured":"Vearrier\u00a0D, Grundmann\u00a0O (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. J\u00a0Clin Pharmacol 61(Suppl 2):S70\u2013S88","journal-title":"J Clin Pharmacol"},{"key":"1691_CR2","volume-title":"Analgetika, Antinoziteptiva, Adjuvantien \u2013 Handbuch f\u00fcr die Schmerzpraxis. Berlin\/Heidelberg\/New York\/Barcelona\/Hongkong\/London\/Mailand\/Paris\/Singapur","author":"B Aicher","year":"2001","unstructured":"Aicher\u00a0B, Beubler\u00a0E, Fox\u00a0JM, Sch\u00e4fer\u00a0M, Stein\u00a0C, Waldvogel\u00a0HH et\u00a0al (2001) Allgemeine Pharmakologie g\u00e4ngiger Schmerzmittel. In: Waldvogel\u00a0HH (Hrsg) Analgetika, Antinoziteptiva, Adjuvantien \u2013 Handbuch f\u00fcr die Schmerzpraxis. Berlin\/Heidelberg\/New York\/Barcelona\/Hongkong\/London\/Mailand\/Paris\/Singapur. Springer, Tokio"},{"key":"1691_CR3","volume-title":"Handbuch Psychoaktive Substanzen: Springer Reference Psychology","author":"T H\u00e4bel","year":"2017","unstructured":"H\u00e4bel\u00a0T, Gutwinski\u00a0S (2017) Opioide. In: von Heyden\u00a0M, Jungaberle\u00a0H, Majic\u00a0T (Hrsg) Handbuch Psychoaktive Substanzen: Springer Reference Psychology"},{"key":"1691_CR4","unstructured":"World Drug Report (2022) https:\/\/www.un-ilibrary.org\/content\/books\/97892100195452022"},{"issue":"1","key":"1691_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13033-021-00512-9","volume":"15","author":"RM Krausz","year":"2021","unstructured":"Krausz\u00a0RM, Westenberg\u00a0JN, Mathew\u00a0N, Budd\u00a0G, Wong\u00a0JSH, Tsang\u00a0VWL et\u00a0al (2021) Shifting North American drug markets and challenges for the system of care. Int J Ment Health Syst 15(1):86","journal-title":"Int J Ment Health Syst"},{"issue":"9","key":"1691_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2215-0366(22)00241-3","volume":"9","author":"RM Krausz","year":"2022","unstructured":"Krausz\u00a0RM, Westenberg\u00a0JN, Meyer\u00a0M, Choi\u00a0F (2022) The upcoming synthetic ultrapotent opioid wave as a\u00a0foreseeable disaster. Lancet Psychiatry 9(9):699\u2013700","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1691_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S2215-0366(17)30479-0","volume":"5","author":"MR Krausz","year":"2018","unstructured":"Krausz\u00a0MR, Jang\u00a0KL (2018) North American opioid crisis: decline and fall of the war on drugs. Lancet Psychiatry 5(1):6\u20138","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"1691_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/YCO.0000000000000712","volume":"34","author":"RM Krausz","year":"2021","unstructured":"Krausz\u00a0RM, Westenberg\u00a0JN, Ziafat\u00a0K (2021) The opioid overdose crisis as a\u00a0global health challenge. Curr Opin Psychiatry 34(4):405\u2013412","journal-title":"Curr Opin Psychiatry"},{"key":"1691_CR9","unstructured":"World Drug Report  (2019) https:\/\/www.un-ilibrary.org\/content\/books\/97892100417442019"},{"key":"1691_CR10","unstructured":"Bundeskriminalamt (2019) Bundeslagebericht Rauschgiftkriminalit\u00e4t 2019. https:\/\/www.bka.de\/SharedDocs\/Downloads\/DE\/Publikationen\/JahresberichteUndLagebilder\/Rauschgiftkriminalitaet\/2019RauschgiftBundeslagebild.html?nn=27972"},{"key":"1691_CR11","unstructured":"Bundeskriminalamt (2022) Bundeslagebericht Rauschgiftkriminalit\u00e4t 2022. https:\/\/www.bka.de\/SharedDocs\/Downloads\/DE\/Publikationen\/JahresberichteUndLagebilder\/Rauschgiftkriminalitaet\/2022RauschgiftBundeslagebild.html?nn=27972"},{"key":"1691_CR12","unstructured":"EMDCCA, Lithuania, Country Drug Report (2019) https:\/\/www.emcdda.europa.eu\/publications\/country-drug-reports\/2019\/lithuania_en"},{"issue":"9","key":"1691_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/anae.16069","volume":"78","author":"M Eikemo","year":"2023","unstructured":"Eikemo\u00a0M, Meier\u00a0IM, Loseth\u00a0GE, Trostheim\u00a0M, Orstavik\u00a0N, Jensen\u00a0EN et\u00a0al (2023) Opioid analgesic effects on subjective well-being in the operating theatre. Anaesthesia 78(9):1102\u20131111","journal-title":"Anaesthesia"},{"issue":"6","key":"1691_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/10826084.2013.863344","volume":"49","author":"S Gutwinski","year":"2014","unstructured":"Gutwinski\u00a0S, Bald\u00a0LK, Gallinat\u00a0J, Heinz\u00a0A, Bermpohl\u00a0F (2014) Why do patients stay in opioid maintenance treatment? Subst Use Misuse 49(6):694\u2013699","journal-title":"Subst Use Misuse"},{"key":"1691_CR15","unstructured":"Richtlinie der Bundes\u00e4rztekammer zur Durchf\u00fchrung der substitutionsgest\u00fctzten Behandlung Opioidabh\u00e4ngiger (Zugegriffen 26. Jan. 2024) [Internet]. 2023."},{"key":"1691_CR16","unstructured":"Substitutionsgest\u00fctzte Behandlung von Opioidabh\u00e4ngigen https:\/\/www.bundesaerztekammer.de\/themen\/aerzte\/public-health\/suchtmedizin\/substitution. Zugegriffen 26. Jan. 2024"},{"key":"1691_CR17","first-page":"405","volume":"110(23\u201324","author":"S Gutwinski","year":"2013","unstructured":"Gutwinski\u00a0S, Bald\u00a0LK, Heinz\u00a0A, Muller\u00a0CA, Schmidt\u00a0AK, Wiers\u00a0C et\u00a0al (2013) Take home maintenance medication in opiate dependence. Dtsch \u00c4rztebl Int 110(23\u201324:405\u2013412","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1691_CR18","first-page":"61","volume-title":"Therapie psychischer Erkrankungen\u2013State of the Art","author":"E Gouzoulis-Mayfrank","year":"2024","unstructured":"Gouzoulis-Mayfrank\u00a0E, Scherbaum\u00a0N (2024) Drogenabh\u00e4ngigkeit. In: Voderholzer\u00a0U, Hohagen\u00a0F (Hrsg) Therapie psychischer Erkrankungen\u2013State of the Art. Urban & Fischer, M\u00fcnchen, Jena, S\u00a061\u201379"},{"key":"1691_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78(9","author":"T Santo Jr.","year":"2021","unstructured":"Santo\u00a0T Jr., Clark\u00a0B, Hickman\u00a0M, Grebely\u00a0J, Campbell\u00a0G, Sordo\u00a0L et\u00a0al (2021) Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A\u00a0Systematic Review and Meta-analysis. Jama Psychiatry 78(9:979\u2013993","journal-title":"Jama Psychiatry"},{"key":"1691_CR20","unstructured":"Bericht zum Subsitutionsregister (2023) https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Bundesopiumstelle\/SubstitReg\/Subst_Bericht2023.html .Zugegriffen 26. Jan. 2024"},{"issue":"1","key":"1691_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/add.14442","volume":"114","author":"C Nordt","year":"2019","unstructured":"Nordt\u00a0C, Vogel\u00a0M, Dey\u00a0M, Moldovanyi\u00a0A, Beck\u00a0T, Berthel\u00a0T et\u00a0al (2019) One size does not fit all-evolution of opioid agonist treatments in a\u00a0naturalistic setting over 23\u00a0years. Addiction 114(1):103\u2013111","journal-title":"Addiction"},{"issue":"5","key":"1691_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood\u00a0TW, Yoon\u00a0GH, Davoust\u00a0MJ, Ogden\u00a0SN, Marshall\u00a0BDL, Cahill\u00a0SR et\u00a0al (2021) Supervised Injection Facilities as Harm Reduction: A\u00a0Systematic Review. Am J Prev Med 61(5):738\u2013749","journal-title":"Am J Prev Med"},{"issue":"6","key":"1691_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/add.16147","volume":"118","author":"DK van Santen","year":"2023","unstructured":"van Santen\u00a0DK, Lodi\u00a0S, Dietze\u00a0P, van den Boom\u00a0W, Hayashi\u00a0K, Dong\u00a0H et\u00a0al (2023) Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis\u00a0c virus acquisition among people who inject drugs in different settings: A\u00a0pooled analysis of emulated trials. Addiction 118(6):1116\u20131126","journal-title":"Addiction"},{"issue":"1","key":"1691_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-017-0156-z","volume":"14","author":"SM Davis","year":"2017","unstructured":"Davis\u00a0SM, Daily\u00a0S, Kristjansson\u00a0AL, Kelley\u00a0GA, Zullig\u00a0K, Baus\u00a0A et\u00a0al (2017) Needle exchange programs for the prevention of hepatitis\u00a0C virus infection in people who inject drugs: a\u00a0systematic review with meta-analysis. Harm Reduct\u00a0J 14(1):25","journal-title":"Harm Reduct J"},{"issue":"2","key":"1691_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","volume":"94","author":"G Fischer","year":"1999","unstructured":"Fischer\u00a0G, Jagsch\u00a0R, Eder\u00a0H, Gombas\u00a0W, Etzersdorfer\u00a0P, Schmidl-Mohl\u00a0K et\u00a0al (1999) Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 94(2):231\u2013239","journal-title":"Addiction"},{"issue":"2","key":"1691_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1151\/spp04224","volume":"2","author":"HE Jones","year":"2004","unstructured":"Jones\u00a0HE (2004) Practical considerations for the clinical use of buprenorphine. Sci Pract Perspect 2(2):4\u201320","journal-title":"Sci Pract Perspect"},{"key":"1691_CR27","unstructured":"WorldHealthOrganisation. Guidelines for the psychologically assisted pharmacological treatment of opioid dependence2009."},{"issue":"13","key":"1691_CR28","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.bmcl.2006.02.017","volume":"16","author":"HS Park","year":"2006","unstructured":"Park\u00a0HS, Lee\u00a0HY, Kim\u00a0YH, Park\u00a0JK, Zvartau\u00a0EE, Lee\u00a0H (2006) A\u00a0highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability. Bioorg Med Chem Lett 16(13):3609\u20133613","journal-title":"Bioorg Med Chem Lett"},{"issue":"456","key":"1691_CR29","doi-asserted-by":"publisher","first-page":"ra117","DOI":"10.1126\/scisignal.aai8441","volume":"9","author":"TF Brust","year":"2016","unstructured":"Brust\u00a0TF, Morgenweck\u00a0J, Kim\u00a0SA, Rose\u00a0JH, Locke\u00a0JL, Schmid\u00a0CL et\u00a0al (2016) Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci Signal 9(456):ra117","journal-title":"Sci Signal"},{"key":"1691_CR30","first-page":"CD002207","volume":"2","author":"RP Mattick","year":"2014","unstructured":"Mattick\u00a0RP, Breen\u00a0C, Kimber\u00a0J, Davoli\u00a0M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2:CD2207","journal-title":"Cochrane Database Syst Rev"},{"key":"1691_CR31","unstructured":"Medizinische Empfehlungen f\u00fcr Opioidagonistentherapie (OAT) bei Opioidabh\u00e4ngigkeits-Syndrom (2020) https:\/\/www.ssam-sapp.ch\/fachleute\/empfehlungen\/opioidagonistentherapie-oat"},{"issue":"6","key":"1691_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt\u00a0L, Clark\u00a0B, Macpherson\u00a0G, Leppan\u00a0O, Nielsen\u00a0S, Zahra\u00a0E et\u00a0al (2023) Buprenorphine versus methadone for the treatment of opioid dependence: a\u00a0systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry 10(6):386\u2013402","journal-title":"Lancet Psychiatry"},{"key":"1691_CR33","first-page":"CD002207","volume":"3","author":"RP Mattick","year":"2004","unstructured":"Mattick\u00a0RP, Kimber\u00a0J, Breen\u00a0C, Davoli\u00a0M (2004) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 3:CD2207","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1691_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-2007-979573","volume":"29","author":"N Scherbaum","year":"1996","unstructured":"Scherbaum\u00a0N, Finkbeiner\u00a0T, Leifert\u00a0K, Gastpar\u00a0M (1996) The efficacy of L\u2011methadone and racemic methadone in substitution treatment for opiate addicts\u2014a double-blind comparison. Pharmacopsychiatry 29(6):212\u2013215","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"1691_CR35","first-page":"82","volume":"41","author":"N Schoofs","year":"2014","unstructured":"Schoofs\u00a0N, Riemer\u00a0T, Bald\u00a0LK, Heinz\u00a0A, Gallinat\u00a0J, Bermpohl\u00a0F et\u00a0al (2014) Methadone and levomethadone\u2014dosage and side effects. Psychiatr Prax 41(2):82\u201387","journal-title":"Psychiatr Prax"},{"issue":"2","key":"1691_CR36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s40429-021-00373-9","volume":"8","author":"J Mielau","year":"2021","unstructured":"Mielau\u00a0J, Vogel\u00a0M, Gutwinski\u00a0S, Mick\u00a0I (2021) New Approaches in Drug Dependence: Opioids. Curr Addict Rep 8(2):298\u2013305","journal-title":"Curr Addict Rep"},{"key":"1691_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-016-0095-0","volume":"13","author":"S Gutwinski","year":"2016","unstructured":"Gutwinski\u00a0S, Schoofs\u00a0N, Stuke\u00a0H, Riemer\u00a0TG, Wiers\u00a0CE, Bermpohl\u00a0F (2016) Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment. Harm Reduct\u00a0J 13:7","journal-title":"Harm Reduct J"},{"issue":"4","key":"1691_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jsat.2014.05.012","volume":"47","author":"R Hammig","year":"2014","unstructured":"Hammig\u00a0R, Kohler\u00a0W, Bonorden-Kleij\u00a0K, Weber\u00a0B, Lebentrau\u00a0K, Berthel\u00a0T et\u00a0al (2014) Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence. J\u00a0Subst Abuse Treat 47(4):275\u2013281","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"1691_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/add.12440","volume":"109","author":"T Beck","year":"2014","unstructured":"Beck\u00a0T, Haasen\u00a0C, Verthein\u00a0U, Walcher\u00a0S, Schuler\u00a0C, Backmund\u00a0M et\u00a0al (2014) Maintenance treatment for opioid dependence with slow-release oral morphine: a\u00a0randomized cross-over, non-inferiority study versus methadone. Addiction 109(4):617\u2013626","journal-title":"Addiction"},{"issue":"2","key":"1691_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/BF02190738","volume":"245","author":"G Bertschy","year":"1995","unstructured":"Bertschy\u00a0G (1995) Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci 245(2):114\u2013124","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1691_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-9089-3","volume-title":"The effectivness of methadone maintance treatment: patients, programs, services and outcome","author":"J Ball","year":"1991","unstructured":"Ball\u00a0J, Ross\u00a0A (1991) The effectivness of methadone maintance treatment: patients, programs, services and outcome. Springer, New York"},{"key":"1691_CR42","unstructured":"NIDA (1995) Methadone maintenance treatment: translating research into policy. National Institute od Drug Abuse, Bethesda"},{"issue":"6","key":"1691_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/ADM.0b013e3182a11ad0","volume":"7","author":"LK Bald","year":"2013","unstructured":"Bald\u00a0LK, Bermpohl\u00a0F, Heinz\u00a0A, Gallinat\u00a0J, Gutwinski\u00a0S (2013) Heroin or conventional opioid maintenance? The patients\u2019 perspective. J\u00a0Addict Med 7(6):401\u2013404","journal-title":"J Addict Med"},{"key":"1691_CR44","first-page":"CD003410","volume":"12","author":"M Ferri","year":"2011","unstructured":"Ferri\u00a0M, Davoli\u00a0M, Perucci\u00a0CA (2011) Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev 12:CD3410","journal-title":"Cochrane Database Syst Rev"},{"key":"1691_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","volume":"191","author":"C Haasen","year":"2007","unstructured":"Haasen\u00a0C, Verthein\u00a0U, Degkwitz\u00a0P, Berger\u00a0J, Krausz\u00a0M, Naber\u00a0D (2007) Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry 191:55\u201362","journal-title":"Br J Psychiatry"},{"key":"1691_CR46","doi-asserted-by":"publisher","first-page":"109869","DOI":"10.1016\/j.drugalcdep.2023.109869","volume":"247","author":"R McNair","year":"2023","unstructured":"McNair\u00a0R, Monaghan\u00a0M, Montgomery\u00a0P (2023) Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A\u00a0context-focused systematic review. Drug Alcohol Depend 247:109869","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1691_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000313334","volume":"16","author":"C Haasen","year":"2010","unstructured":"Haasen\u00a0C, Verthein\u00a0U, Eiroa-Orosa\u00a0FJ, Schafer\u00a0I, Reimer\u00a0J (2010) Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a\u00a0German randomised controlled trial. Eur Addict Res 16(3):124\u2013130","journal-title":"Eur Addict Res"},{"key":"1691_CR48","doi-asserted-by":"publisher","first-page":"103548","DOI":"10.1016\/j.drugpo.2021.103548","volume":"101","author":"M Meyer","year":"2022","unstructured":"Meyer\u00a0M, Strasser\u00a0J, Kock\u00a0P, Walter\u00a0M, Vogel\u00a0M, Dursteler\u00a0KM (2022) Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic\u2014Is an update of legal restrictions warranted? Int J Drug Policy 101:103548","journal-title":"Int J Drug Policy"},{"issue":"7503","key":"1691_CR49","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","volume":"330","author":"MG Dijkgraaf","year":"2005","unstructured":"Dijkgraaf\u00a0MG, van der Zanden\u00a0BP, de Borgie\u00a0CA, Blanken\u00a0P, van Ree\u00a0JM, van den Brink\u00a0W (2005) Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ 330(7503):1297","journal-title":"BMJ"},{"issue":"3","key":"1691_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.drugalcdep.2008.01.015","volume":"95","author":"HU Wittchen","year":"2008","unstructured":"Wittchen\u00a0HU, Apelt\u00a0SM, Soyka\u00a0M, Gastpar\u00a0M, Backmund\u00a0M, Golz\u00a0J et\u00a0al (2008) Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a\u00a0naturalistic study in 2694 patients. Drug Alcohol Depend 95(3):245\u2013257","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1691_CR51","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1213\/01.ANE.0000132927.47528.8B","volume":"99","author":"AC Rudy","year":"2004","unstructured":"Rudy\u00a0AC, Coda\u00a0BA, Archer\u00a0SM, Wermeling\u00a0DP (2004) A\u00a0multiple-dose phase\u00a0I\u00a0study of intranasal hydromorphone hydrochloride in healthy volunteers. Anesth Analg 99(5):1379\u20131386","journal-title":"Anesth Analg"},{"key":"1691_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jama.2016.9382","volume":"316(3","author":"RN Rosenthal","year":"2016","unstructured":"Rosenthal\u00a0RN, Lofwall\u00a0MR, Kim\u00a0S, Chen\u00a0M, Beebe\u00a0KL, Vocci\u00a0FJ et\u00a0al (2016) Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A\u00a0Randomized Clinical Trial. JAMA 316(3:282\u2013290","journal-title":"JAMA"},{"key":"1691_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/SAR.S155843","volume":"10","author":"W Ling","year":"2019","unstructured":"Ling\u00a0W, Shoptaw\u00a0S, Goodman-Meza\u00a0D (2019) Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation. Subst Abuse Rehabil 10:69\u201378","journal-title":"Subst Abuse Rehabil"},{"issue":"1","key":"1691_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13011-020-00262-w","volume":"15","author":"K Bohmer","year":"2020","unstructured":"Bohmer\u00a0K, Schecke\u00a0H, Render\u00a0I, Scherbaum\u00a0N (2020) Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany\u2014a\u00a0top down approach. Subst Abuse Treat Prev Policy 15(1):21","journal-title":"Subst Abuse Treat Prev Policy"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01691-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:04:01Z","timestamp":1725455041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01691-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01691-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"31 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Heinz, S.\u00a0Gutwinski, M.\u00a0Krausz, G.\u00a0Ernst, M.\u00a0Vogel und N.\u00a0Scherbaum geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}